Menu Close

Anogenital Human Papillomavirus Infection and HIV Infection Outcomes among Peruvian Transgender Women: Results from a Cohort Study

Citation

Brown, Brandon; Galea, Jerome T.; Byraiah, Gita; Poteat, Tonia; Leon, Segundo R.; Calvo, Gino; Sánchez, Hugo; Coates, Thomas; & Klausner, Jeffrey D. (2016). Anogenital Human Papillomavirus Infection and HIV Infection Outcomes among Peruvian Transgender Women: Results from a Cohort Study. Transgender Health, 1(1), 94-8. PMCID: PMC5685267

Abstract

Latin American transgender women are highly vulnerable to HIV infection, and although much is known about factors associated with HIV infection in this population, little is known about the association of human papilloma virus (HPV) with HIV infection. We investigated anogenital HPV and cumulative HIV incidence among 68, initially HIV uninfected, Peruvian transgender women enrolled into a 2-year, prospective cohort study: 95.6% had at least one anogenital HPV genotype at baseline, 19.1% had visible anogenital warts, and 6.0% became infected with HIV over the course of the study. Due to the high anogenital HPV prevalence, this population would likely benefit from early immunization with the HPV vaccine.

URL

http://dx.doi.org/10.1089/trgh.2016.0001

Reference Type

Journal Article

Journal Title

Transgender Health

Author(s)

Brown, Brandon
Galea, Jerome T.
Byraiah, Gita
Poteat, Tonia
Leon, Segundo R.
Calvo, Gino
Sánchez, Hugo
Coates, Thomas
Klausner, Jeffrey D.

Year Published

2016

Volume Number

1

Issue Number

1

Pages

94-8

PMCID

PMC5685267

Reference ID

12888